List of Excipients in API tofacitinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tofacitinib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | XELJANZ | tofacitinib | 0069-1001 | CELLULOSE, MICROCRYSTALLINE | |
| Pfizer Laboratories Div Pfizer Inc | XELJANZ | tofacitinib | 0069-1001 | CROSCARMELLOSE SODIUM | |
| Pfizer Laboratories Div Pfizer Inc | XELJANZ | tofacitinib | 0069-1001 | HYPROMELLOSE 2910 | |
| Pfizer Laboratories Div Pfizer Inc | XELJANZ | tofacitinib | 0069-1001 | LACTOSE MONOHYDRATE | |
| Pfizer Laboratories Div Pfizer Inc | XELJANZ | tofacitinib | 0069-1001 | MAGNESIUM STEARATE | |
| Pfizer Laboratories Div Pfizer Inc | XELJANZ | tofacitinib | 0069-1001 | POLYETHYLENE GLYCOL 3350 | |
| Pfizer Laboratories Div Pfizer Inc | XELJANZ | tofacitinib | 0069-1001 | TITANIUM DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tofacitinib
Detailed excipient profiles for tofacitinib
Excipient focus: AMMONIA
tofacitinib drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | tofacitinib citrate | 0574-1811 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing AMMONIA
Excipient focus: BROWN IRON OXIDE
tofacitinib drug variants containing BROWN IRON OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing BROWN IRON OXIDE
Excipient focus: BUTYLATED HYDROXYTOLUENE
tofacitinib drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | tofacitinib | 59651-685 |
| Golden State Medical Supply Inc | tofacitinib | 84677-048 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CELLULOSE ACETATE
tofacitinib drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | tofacitinib | 59651-685 |
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| Golden State Medical Supply Inc | tofacitinib | 84677-048 |
| Padagis US LLC | tofacitinib citrate | 0574-1811 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing CELLULOSE ACETATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tofacitinib drug variants containing CELLULOSE, MICROCRYSTALLINE
tofacitinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COPOVIDONE K25-31
tofacitinib drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | tofacitinib | 59651-685 |
| Golden State Medical Supply Inc | tofacitinib | 84677-048 |
| Padagis US LLC | tofacitinib citrate | 0574-1811 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
tofacitinib drug variants containing CROSCARMELLOSE SODIUM
tofacitinib drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 27 ALUMINUM LAKE
tofacitinib drug variants containing D&C RED NO. 27 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | tofacitinib | 70710-1353 |
| Zydus Lifesciences Limited | tofacitinib | 70771-1627 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing D&C RED NO. 27 ALUMINUM LAKE
Excipient focus: DIBUTYL SEBACATE
tofacitinib drug variants containing DIBUTYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | tofacitinib | 60505-4858 |
| AvKARE | tofacitinib | 73190-102 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing DIBUTYL SEBACATE
Excipient focus: ETHYLCELLULOSE
tofacitinib drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | tofacitinib | 60505-4858 |
| Zydus Pharmaceuticals USA Inc | tofacitinib | 70710-1353 |
| Zydus Lifesciences Limited | tofacitinib | 70771-1627 |
| AvKARE | tofacitinib | 73190-102 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
tofacitinib drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | tofacitinib | 70710-1353 |
| Zydus Lifesciences Limited | tofacitinib | 70771-1627 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FERRIC OXIDE RED
tofacitinib drug variants containing FERRIC OXIDE RED
tofacitinib drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
tofacitinib drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tofacitinib | 27241-270 |
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| Padagis US LLC | tofacitinib citrate | 0574-1811 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
tofacitinib drug variants containing FERROSOFERRIC OXIDE
tofacitinib drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: FRUCTOSE
tofacitinib drug variants containing FRUCTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing FRUCTOSE
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
tofacitinib drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
Excipient focus: GRAPE
tofacitinib drug variants containing GRAPE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing GRAPE
Excipient focus: HYDROCHLORIC ACID
tofacitinib drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYETHYL CELLULOSE
tofacitinib drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | tofacitinib | 59651-685 |
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| Golden State Medical Supply Inc | tofacitinib | 84677-048 |
| Padagis US LLC | tofacitinib citrate | 0574-1811 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
tofacitinib drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | tofacitinib | 42799-970 |
| Aurobindo Pharma Limited | tofacitinib | 59651-685 |
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| Golden State Medical Supply Inc | tofacitinib | 84677-048 |
| Padagis US LLC | tofacitinib citrate | 0574-1811 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
tofacitinib drug variants containing HYPROMELLOSE
tofacitinib drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
tofacitinib drug variants containing HYPROMELLOSE 2208
tofacitinib drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
tofacitinib drug variants containing HYPROMELLOSE 2910
tofacitinib drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTIC ACID
tofacitinib drug variants containing LACTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing LACTIC ACID
Excipient focus: LACTOSE MONOHYDRATE
tofacitinib drug variants containing LACTOSE MONOHYDRATE
tofacitinib drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
tofacitinib drug variants containing MAGNESIUM STEARATE
tofacitinib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
tofacitinib drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | tofacitinib | 42799-970 |
| Apotex Corp | tofacitinib | 60505-4858 |
| AvKARE | tofacitinib | 73190-102 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing MANNITOL
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
tofacitinib drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | tofacitinib | 60505-4858 |
| AvKARE | tofacitinib | 73190-102 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: METHYLCELLULOSE
tofacitinib drug variants containing METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | tofacitinib | 60505-6263 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing METHYLCELLULOSE
Excipient focus: POLYETHYLENE GLYCOL
tofacitinib drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tofacitinib | 27241-270 |
| ScieGen Pharmaceuticals INC | tofacitinib citrate | 50228-567 |
| Breckenridge Pharmaceutical Inc | tofacitinib citrate | 51991-329 |
| Radha Pharmaceuticals Inc | tofacitinib citrate | 77771-567 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
tofacitinib drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | tofacitinib | 0069-1001 |
| Macleods Pharmaceuticals Limited | tofacitinib | 33342-541 |
| Apotex Corp | tofacitinib | 60505-6263 |
| US Pharmaceuticals | tofacitinib | 63539-012 |
| Biocon Pharma Inc | tofacitinib | 70377-057 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-139 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
tofacitinib drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Somerset Therapeutics LLC | tofacitinib | 70069-841 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
tofacitinib drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Micro Labs Limited | tofacitinib | 42571-268 |
| Aurobindo Pharma Limited | tofacitinib | 59651-459 |
| Zydus Pharmaceuticals USA Inc | tofacitinib | 70710-1353 |
| Zydus Lifesciences Limited | tofacitinib | 70771-1627 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
tofacitinib drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | tofacitinib | 70710-1243 |
| Zydus Lifesciences Limited | tofacitinib | 70771-1821 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE OXIDE 200000
tofacitinib drug variants containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | tofacitinib | 59651-685 |
| Golden State Medical Supply Inc | tofacitinib | 84677-048 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POLYETHYLENE OXIDE 200000
Excipient focus: POLYVINYL ALCOHOL
tofacitinib drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tofacitinib | 27241-270 |
| Biocon Pharma Inc | tofacitinib | 70377-057 |
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| ScieGen Pharmaceuticals INC | tofacitinib citrate | 50228-567 |
| Radha Pharmaceuticals Inc | tofacitinib citrate | 77771-567 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
tofacitinib drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tofacitinib | 27241-270 |
| ScieGen Pharmaceuticals INC | tofacitinib citrate | 50228-567 |
| Radha Pharmaceuticals Inc | tofacitinib citrate | 77771-567 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
tofacitinib drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | tofacitinib | 70710-1243 |
| Zydus Lifesciences Limited | tofacitinib | 70771-1821 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
tofacitinib drug variants containing PROPYLENE GLYCOL
tofacitinib drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
tofacitinib drug variants containing SHELLAC
tofacitinib drug variants not containing SHELLAC
Excipient focus: SILICA DIMETHYL SILYLATE
tofacitinib drug variants containing SILICA DIMETHYL SILYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | tofacitinib | 27241-270 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing SILICA DIMETHYL SILYLATE
Excipient focus: SILICON DIOXIDE
tofacitinib drug variants containing SILICON DIOXIDE
tofacitinib drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ACETATE
tofacitinib drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM BENZOATE
tofacitinib drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM HYDROXIDE
tofacitinib drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
tofacitinib drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Biocon Pharma Inc | tofacitinib | 70377-057 |
| Zydus Pharmaceuticals USA Inc | tofacitinib | 70710-1353 |
| Zydus Lifesciences Limited | tofacitinib | 70771-1627 |
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SORBITOL
tofacitinib drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| Padagis US LLC | tofacitinib citrate | 0574-1811 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
tofacitinib drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Exelan pharmaceuticalsInc | tofacitinib | 76282-816 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing STARCH, CORN
Excipient focus: SUCRALOSE
tofacitinib drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing SUCRALOSE
Excipient focus: TALC
tofacitinib drug variants containing TALC
tofacitinib drug variants not containing TALC
Excipient focus: TARTARIC ACID
tofacitinib drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing TARTARIC ACID
Excipient focus: TITANIUM DIOXIDE
tofacitinib drug variants containing TITANIUM DIOXIDE
tofacitinib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| Apotex Corp | tofacitinib | 60505-4858 |
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| AvKARE | tofacitinib | 73190-102 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
tofacitinib drug variants containing TRIACETIN
tofacitinib drug variants not containing TRIACETIN
Excipient focus: WATER
tofacitinib drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| Novadoz Pharmaceuticals LLC | tofacitinib | 72205-121 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing WATER
Excipient focus: WINE GRAPE
tofacitinib drug variants containing WINE GRAPE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | tofacitinib | 0054-0821 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing WINE GRAPE
Excipient focus: XYLITOL
tofacitinib drug variants containing XYLITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | tofacitinib | 70095-008 |
| IPG Pharmaceuticals Inc | tofacitinib | 71085-099 |
| >Company | >Ingredient | >NDC |
tofacitinib drug variants not containing XYLITOL
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links